The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma. Journal of the American Academy fo Dermatology Dummer, R., Guminski, A., Gutzmer, R., Dirix, L., Lewis, K. D., Combemale, P., Herd, R., Kaatz, M., Loquai, C., Stratigos, A. J., Schulze, H., Plummer, R., Gogov, S., Pallaud, C., Yi, T., Mone, M., Chang, A. S., Cornelis, F., Kudchadkar, R., Trefzer, U., Lear, J., Sellami, D., Migden, M. 2016

View details for DOI 10.1016/j.jaad.2016.02.1226. Epub 2016 Apr 7.